Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleSystemic Sclerosis

Comparison of Warrick Scoring and Goh Staging for Detecting Progression in Systemic Sclerosis–Associated Interstitial Lung Disease

Gülşah Yamancan, Ahmet Karataş, Damla Arslan, Sümeyye Sahin, Yusuf Dogan, Jehat Kılıç, Burak Öz, Hakan Artas and Süleyman Serdar Koca
The Journal of Rheumatology October 2026, 53 (10) 1109-1116; DOI: https://doi.org/10.3899/jrheum.2026-0185
Gülşah Yamancan
1G. Yamancan, MD, A. Karataş, MD, S. Sahin, MD, Y. Dogan, MD, J. Kılıç, MD, B. Öz, MD, S.S. Koca, MD, Department of Rheumatology, Fırat University Faculty of Medicine, Elazığ;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gülşah Yamancan
  • For correspondence: gulsahaydn{at}windowslive.com
Ahmet Karataş
1G. Yamancan, MD, A. Karataş, MD, S. Sahin, MD, Y. Dogan, MD, J. Kılıç, MD, B. Öz, MD, S.S. Koca, MD, Department of Rheumatology, Fırat University Faculty of Medicine, Elazığ;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ahmet Karataş
Damla Arslan
2D. Arslan, MD, H. Artas, MD, Department of Radiology, Fırat University Faculty of Medicine, Elazığ, Türkiye.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Damla Arslan
Sümeyye Sahin
1G. Yamancan, MD, A. Karataş, MD, S. Sahin, MD, Y. Dogan, MD, J. Kılıç, MD, B. Öz, MD, S.S. Koca, MD, Department of Rheumatology, Fırat University Faculty of Medicine, Elazığ;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sümeyye Sahin
Yusuf Dogan
1G. Yamancan, MD, A. Karataş, MD, S. Sahin, MD, Y. Dogan, MD, J. Kılıç, MD, B. Öz, MD, S.S. Koca, MD, Department of Rheumatology, Fırat University Faculty of Medicine, Elazığ;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yusuf Dogan
Jehat Kılıç
1G. Yamancan, MD, A. Karataş, MD, S. Sahin, MD, Y. Dogan, MD, J. Kılıç, MD, B. Öz, MD, S.S. Koca, MD, Department of Rheumatology, Fırat University Faculty of Medicine, Elazığ;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jehat Kılıç
Burak Öz
1G. Yamancan, MD, A. Karataş, MD, S. Sahin, MD, Y. Dogan, MD, J. Kılıç, MD, B. Öz, MD, S.S. Koca, MD, Department of Rheumatology, Fırat University Faculty of Medicine, Elazığ;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Burak Öz
Hakan Artas
2D. Arslan, MD, H. Artas, MD, Department of Radiology, Fırat University Faculty of Medicine, Elazığ, Türkiye.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hakan Artas
Süleyman Serdar Koca
1G. Yamancan, MD, A. Karataş, MD, S. Sahin, MD, Y. Dogan, MD, J. Kılıç, MD, B. Öz, MD, S.S. Koca, MD, Department of Rheumatology, Fırat University Faculty of Medicine, Elazığ;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Süleyman Serdar Koca
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

Abstract

Objective Interstitial lung disease (ILD) is the leading cause of mortality in systemic sclerosis (SSc). The Warrick semiquantitative scoring system and the Goh staging algorithm provide different approaches for assessing lung involvement on high-resolution computed tomography (HRCT). We compared their sensitivity for detecting radiological progression in SSc-ILD.

Methods We retrospectively analyzed 33 patients with SSc-ILD who underwent serial HRCT examinations. Each scan was evaluated using the Warrick score (0-30) and Goh staging (limited/extensive). Progression was defined as an increase of ≥ 3 points in the Warrick score or transition from limited to extensive disease by Goh staging. Comparative progression analysis was restricted to the 24 patients with baseline limited disease, as only these patients were eligible for Goh-defined progression. Progression rates were compared using the McNemar test, and receiver-operating characteristics analysis assessed Warrick score thresholds for identifying Goh-defined extensive disease.

Results The cohort included 33 patients (85% female; mean age 53.2 [SD 8.9] years), all with diffuse cutaneous SSc. At baseline, 24 (73%) had limited disease and 9 (27%) had extensive disease. Among patients with baseline limited disease, Warrick scoring identified progression in 15 (62%) compared with 8 (33%) by Goh staging (McNemar chi-square test 7.00, P = 0.01). All Goh progressors also fulfilled Warrick progression criteria, whereas 7 additional patients showed Warrick progression without stage transition. Among baseline extensive patients, 6 (67%) demonstrated further radiological worsening according to Warrick scoring. Follow-up Warrick scores showed excellent discrimination for Goh-defined extensive disease (area under the curve 0.94, 95% CI 0.86-1.00), with an optimal threshold of 20 points (sensitivity 88%, specificity 88%). Agreement between methods was substantial (Cohen κ 0.76).

Conclusion Warrick scoring was significantly more sensitive than Goh staging for detecting radiological progression in SSc-ILD and remained informative in patients already classified as having extensive disease, supporting its use in longitudinal monitoring.

Key Indexing Terms:
  • computed tomography
  • disease progression
  • interstitial lung disease
  • receiver-operating characteristic curve
  • systemic sclerosis
  • Accepted for publication June 29, 2026.
  • Copyright © 2026 by the Journal of Rheumatology
View Full Text

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

The Journal of Rheumatology: 53 (10)
The Journal of Rheumatology
Vol. 53, Issue 10
1 Oct 2026
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparison of Warrick Scoring and Goh Staging for Detecting Progression in Systemic Sclerosis–Associated Interstitial Lung Disease
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Comparison of Warrick Scoring and Goh Staging for Detecting Progression in Systemic Sclerosis–Associated Interstitial Lung Disease
Gülşah Yamancan, Ahmet Karataş, Damla Arslan, Sümeyye Sahin, Yusuf Dogan, Jehat Kılıç, Burak Öz, Hakan Artas, Süleyman Serdar Koca
The Journal of Rheumatology Oct 2026, 53 (10) 1109-1116; DOI: 10.3899/jrheum.2026-0185

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Comparison of Warrick Scoring and Goh Staging for Detecting Progression in Systemic Sclerosis–Associated Interstitial Lung Disease
Gülşah Yamancan, Ahmet Karataş, Damla Arslan, Sümeyye Sahin, Yusuf Dogan, Jehat Kılıç, Burak Öz, Hakan Artas, Süleyman Serdar Koca
The Journal of Rheumatology Oct 2026, 53 (10) 1109-1116; DOI: 10.3899/jrheum.2026-0185
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • Abstract
    • METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Keywords

COMPUTED TOMOGRAPHY
DISEASE PROGRESSION
INTERSTITIAL LUNG DISEASE
receiver-operating characteristic curve
SYSTEMIC SCLEROSIS

Related Articles

Cited By...

More in this TOC Section

  • Autoantibodies and Relapse of Systemic Sclerosis After Autologous Hematopoietic Cell Transplantation
  • Real-World Adherence to Systemic Sclerosis Quality Indicators: A Single-Center Quality of Care Study
Show more Systemic Sclerosis

Similar Articles

Keywords

  • computed tomography
  • disease progression
  • interstitial lung disease
  • receiver-operating characteristic curve
  • systemic sclerosis

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire